Common use of Notice of Optional Redemption Clause in Contracts

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. 84 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 Section 17.09. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2, 2017 between Flexion Therapeutics, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.0316.03 . Payment of Notes Called for Redemption 83 84 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 Section 17.0217.02 . Official Acts by Successor Corporation 84 Section 17.0317.03 . Addresses for Notices, Etc. 84 85 Section 17.0417.04 . Governing Law; Jurisdiction 85 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.0617.06 . Legal Holidays 86 Section 17.0717.07 . No Security Interest Created 86 87 Section 17.0817.08 . Benefits of Indenture 86 87 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Section 17.1017.10 . Authenticating Agent 87 Section 17.1117.11 . Execution in Counterparts 88 Section 17.1217.12 . Severability 88 Section 17.1317.13 . Waiver of Jury Trial 88 Section 17.1417.14 . Force Majeure 88 Section 17.1517.15 . Calculations 88 89 Section 17.1617.16 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2September 21, 2017 2018 between Flexion Therapeutics, Inc.SPLUNK INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 79 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 81 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 81 Section 17.02. Official Acts by Successor Corporation 84 81 Section 17.03. Addresses for Notices, Etc. 84 Etc 81 Section 17.04. Governing Law; Jurisdiction 85 82 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.06. Legal Holidays 86 83 Section 17.07. No Security Interest Created 86 83 Section 17.08. Benefits of Indenture 86 83 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 83 Section 17.10. Authenticating Agent 87 83 Section 17.11. Execution in Counterparts 88 84 Section 17.12. Severability 88 85 Section 17.13. Waiver of Jury Trial 88 85 Section 17.14. Force Majeure 88 85 Section 17.15. Calculations 88 85 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 85 Section 17.17. Foreign Account Tax Compliance Act (FATCA) 85 INDENTURE dated as of May 2September 9, 2017 2019 between Flexion TherapeuticsZillow Group, Inc., a Delaware Washington corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankThe Bank of New York Mellon Trust Company, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 90 Section 16.03. Payment of Notes Called for Redemption 83 92 Section 16.04. 16.04 Restrictions on Redemption 84 92 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 92 Section 17.02. Official Acts by Successor Corporation 84 92 Section 17.03. Addresses for Notices, Etc. 84 93 Section 17.04. Governing Law; Jurisdiction 85 93 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 94 Section 17.06. Legal Holidays 86 94 Section 17.07. No Security Interest Created 86 94 Section 17.08. Benefits of Indenture 86 95 Section 17.09. Table of Contents, Headings, Etc. 87 95 Section 17.10. Authenticating Agent 87 95 Section 17.11. Execution in Counterparts 88 96 Section 17.12. Severability 88 96 Section 17.13. Waiver of Jury Trial 88 96 Section 17.14. Force Majeure 88 96 Section 17.15. Calculations 88 96 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 97 Section 17.17. Tax Withholding 97 INDENTURE dated as of May 2December 16, 2017 2019 between Flexion TherapeuticsIMPINJ, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation Company 84 Section 17.03. Addresses for Notices, Etc. Etc 84 Section 17.04. Governing Law; Jurisdiction Law 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 85 Section 17.06. Legal Holidays 86 85 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 86 Section 17.10. Authenticating Agent 87 86 Section 17.11. Execution in Counterparts 88 87 Section 17.12. Severability 88 87 Section 17.13. Waiver of Jury Trial 88 87 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 Exhibit A Form of Note A-1 88 INDENTURE dated as of May 2December 23, 2017 2011 between Flexion TherapeuticsConceptus, Inc., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.0316.03 . Payment of Notes Called for Redemption 83 90 Section 16.0416.04 . Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 91 Section 17.0217.02 . Official Acts by Successor Corporation 84 91 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 91 Section 17.0417.04 . Governing Law; Jurisdiction 85 92 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.0617.06 . Legal Holidays 86 93 Section 17.0717.07 . No Security Interest Created 86 93 Section 17.0817.08 . Benefits of Indenture 86 93 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 93 Section 17.1017.10 . Authenticating Agent 87 93 Section 17.1117.11 . Execution in Counterparts 88 94 Section 17.1217.12 . Severability 88 95 Section 17.1317.13 . Waiver of Jury Trial 88 95 Section 17.1417.14 . Force Majeure 88 95 Section 17.1517.15 . Calculations 88 96 Section 17.1617.16 . USA PATRIOT Act 89 96 Section 17.17 . Tax Withholding 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2November 30, 2017 2020 between Flexion Therapeutics▇▇▇▇.▇▇▇ HOLDINGS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 89 Section 17.16. USA U.S.A. PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2August 13, 2017 2018, between Flexion TherapeuticsRAPID7, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.0316.03 . Payment of Notes Called for Redemption 83 91 Section 16.0416.04 . Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 91 Section 17.0217.02 . Official Acts by Successor Corporation 84 91 Section 17.0317.03 . Addresses for Notices, Etc. 84 92 Section 17.0417.04 . Governing Law; Jurisdiction 85 92 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.0617.06 . Legal Holidays 86 93 Section 17.0717.07 . No Security Interest Created 86 93 Section 17.0817.08 . Benefits of Indenture 86 93 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 94 Section 17.1017.10 . Authenticating Agent 87 94 Section 17.1117.11 . Execution in Counterparts 88 95 Section 17.1217.12 . Severability 88 95 Section 17.1317.13 . Waiver of Jury Trial 88 95 Section 17.1417.14 . Force Majeure 88 95 Section 17.1517.15 . Calculations 88 96 Section 17.1617.16 . USA PATRIOT Act 89 96 Section 17.17 . Tax Withholding 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2August 13, 2017 2021 between Flexion TherapeuticsCLOUDFLARE, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 90 Section 16.03. Payment of Notes Called for Redemption 83 92 Section 16.04. Restrictions on Redemption 84 92 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 93 Section 17.02. Official Acts by Successor Corporation 84 Entity 93 Section 17.03. Addresses for Notices, Etc. 84 93 Section 17.04. Governing Law; Jurisdiction 85 94 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 94 Section 17.06. Legal Holidays 86 95 Section 17.07. No Security Interest Created 86 95 Section 17.08. Benefits of Indenture 86 95 Section 17.09. Table of Contents, Headings, Etc. 87 95 Section 17.10. Authenticating Agent 87 95 Section 17.11. Execution in Counterparts 88 97 Section 17.12. Severability 88 97 Section 17.13. Waiver of Jury Trial 88 97 Section 17.14. Force Majeure 88 97 Section 17.15. Calculations 88 97 Section 17.16. USA PATRIOT Act 89 98 Section 17.17. Electronic Signatures 98 Exhibit A Form of Note A-1 INDENTURE dated as of May 2December 12, 2017 2024 between Flexion TherapeuticsDATADOG, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 84 Section 16.03. Payment of Notes Called for Redemption 83 86 Section 16.04. Restrictions on Redemption 84 86 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 86 Section 17.02. Official Acts by Successor Corporation 84 Person 87 Section 17.03. Addresses for Notices, Etc. 84 Etc 87 Section 17.04. Governing Law; Jurisdiction 85 88 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 88 Section 17.06. Legal Holidays 86 89 Section 17.07. No Security Interest Created 86 89 Section 17.08. Benefits of Indenture 86 89 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 89 Section 17.10. Authenticating Agent 87 89 Section 17.11. Execution in Counterparts 88 90 Section 17.12. Severability 88 90 Section 17.13. Waiver of Jury Trial 88 90 Section 17.14. Force Majeure 88 90 Section 17.15. Calculations 88 91 Section 17.16. USA PATRIOT Act 89 91 Section 17.17. Withholding Taxes 91 Section 17.18. Electronic Signatures 91 Exhibit A Form of Note A-1 Exhibit B Form of Free Transferability Certificate B-1 INDENTURE dated as of May 212, 2017 2023 between Flexion Therapeutics, Inc.WAYFAIR INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).. In order to declare the terms and conditions upon which the Company’s 3.50% Convertible Senior Notes due 2028 (the “Notes”) are, and are to be, authenticated, issued and delivered, and in consideration of the premises and of the purchase and acceptance of the Notes by the Holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective Holders from time to time of the Notes (except as otherwise provided below), as follows:

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.03. Payment of Notes Called for Redemption 83 85 Section 16.04. Restrictions on Redemption 84 85 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 85 Section 17.03. Addresses for Notices, Etc. 84 Etc 85 Section 17.04. Governing Law; Jurisdiction 85 86 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 87 Section 17.06. Legal Holidays 86 87 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 88 Section 17.10. Authenticating Agent 87 88 Section 17.11. Execution in Counterparts 88 89 Section 17.12. Severability 88 89 Section 17.13. Waiver of Jury Trial 88 89 Section 17.14. Force Majeure 88 89 Section 17.15. Calculations 88 89 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 90 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2June 8, 2017 2020, between Flexion TherapeuticsPALO ALTO NETWORKS, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, U.S. Bank National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 78 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 80 Section 17.01. Provisions Binding on Company’s Successors 84 80 Section 17.02. Official Acts by Successor Corporation 84 80 Section 17.03. Addresses for Notices, Etc. 84 Etc 80 Section 17.04. Governing Law; Jurisdiction 85 81 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.06. Legal Holidays 86 82 Section 17.07. No Security Interest Created 86 82 Section 17.08. Benefits of Indenture 86 82 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 83 Section 17.10. Authenticating Agent 87 83 Section 17.11. Execution in Counterparts 88 84 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 84 Section 17.16. USA PATRIOT Act 89 85 Section 17.17. Electronic Signatures 85 Exhibit A Form of Note A-1 INDENTURE dated as of May 2March 8, 2017 2024 between Flexion TherapeuticsTANDEM DIABETES CARE, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.06. Legal Holidays 86 92 Section 17.07. No Security Interest Created 86 92 Section 17.08. Benefits of Indenture 86 92 Section 17.09. Table of Contents, Headings, Etc. 87 92 Section 17.10. Authenticating Agent 87 92 Section 17.11. Execution in Counterparts 88 93 Section 17.12. Severability 88 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 94 Section 17.15. Calculations 88 94 Section 17.16. USA U.S.A. PATRIOT Act 89 Exhibit A Form 95 Section 17.17. No Personal Liability of Note A-1 INDENTURE Directors, Officers, Employees or Stockholders 95 INDENTURE, dated as of May 2October 1, 2017 2021, between Flexion Therapeutics, Inc.BROOKDALE SENIOR LIVING INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankAMERICAN STOCK TRANSFER & TRUST COMPANY, National AssociationLLC, a national banking association organized under the laws of the United States of AmericaNew York limited liability trust company, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 84 Section 16.03. Payment of Notes Called for Redemption 83 85 Section 16.04. Restrictions on Redemption 84 86 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 86 Section 17.02. Official Acts by Successor Corporation 84 86 Section 17.03. Addresses for Notices, Etc. 84 Etc 86 Section 17.04. Governing Law; Jurisdiction 85 87 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 87 Section 17.06. Legal Holidays 86 88 Section 17.07. No Security Interest Created 86 88 Section 17.08. Benefits of Indenture 86 88 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 88 Section 17.10. Authenticating Agent 87 88 Section 17.11. Execution in Counterparts 88 89 Section 17.12. Severability 88 89 Section 17.13. Waiver of Jury Trial 88 90 Section 17.14. Force Majeure 88 90 Section 17.15. Calculations 88 90 Section 17.16. USA PATRIOT Act 89 90 Exhibit A Form of Note A-1 INDENTURE dated as of May 2November 5, 2017 2014 between Flexion TherapeuticsEuronet Worldwide, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, U.S. Bank National Association, a national banking association organized under the laws of the United States of AmericaStates, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.03. Payment of Notes Called for Redemption 83 91 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 91 Section 17.01. Provisions Binding on Company’s Successors 84 91 Section 17.02. Official Acts by Successor Corporation 84 91 Section 17.03. Addresses for Notices, Etc. 84 91 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 94 Section 17.08. Benefits of Indenture 86 94 Section 17.09. Table of Contents, Headings, Etc. 87 94 Section 17.10. Authenticating Agent 87 94 Section 17.11. Execution in Counterparts 88 95 Section 17.12. Severability 88 96 Section 17.13. Waiver of Jury Trial 88 96 Section 17.14. Force Majeure 88 96 Section 17.15. Calculations 88 96 Section 17.16. USA PATRIOT Act 89 96 Section 17.17. Tax Withholding 97 Exhibit A Form of Note A-1 INDENTURE dated as of May 231, 2017 2024 between Flexion Therapeutics, Inc.MICROCHIP TECHNOLOGY INCORPORATED, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankCOMPUTERSHARE TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association and limited purpose trust company organized under the laws of the United States of AmericaStates, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.0316.03 . Payment of Notes Called for Redemption 83 88 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 88 Section 17.0117.01 . Provisions Binding on Company’s Successors 84 88 Section 17.0217.02 . Official Acts by Successor Corporation 84 88 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 89 Section 17.0417.04 . Governing Law; Jurisdiction 85 89 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.0617.06 . Legal Holidays 86 91 Section 17.0717.07 . No Security Interest Created 86 91 Section 17.0817.08 . Benefits of Indenture 86 91 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 91 Section 17.1017.10 . Authenticating Agent 87 91 Section 17.1117.11 . Execution in Counterparts 88 92 Section 17.1217.12 . Severability 88 92 Section 17.1317.13 . Waiver of Jury Trial 88 92 Section 17.1417.14 . Force Majeure 88 93 Section 17.1517.15 . Calculations 88 93 Section 17.1617.16 . USA PATRIOT Act 89 93 Section 17.17. Electronic signatures 93 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 5, 2017 2020 between Flexion Therapeutics, Inc.SPLUNK INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 85 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 86 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 87 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 89 Section 17.13. Waiver of Jury Trial 88 89 Section 17.14. Force Majeure 88 89 Section 17.15. Calculations 88 89 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 12, 2017 2018 between Flexion TherapeuticsMINDBODY, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 92 Section 17.08. Benefits of Indenture 86 92 Section 17.09. Table of Contents, Headings, Etc. 87 92 Section 17.10. Authenticating Agent 87 92 Section 17.11. Execution in Counterparts 88 93 Section 17.12. Severability 88 93 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 94 Section 17.16. USA PATRIOT Act 89 94 Section 17.17. Electronic Signatures 94 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 12, 2017 2023 between Flexion TherapeuticsIONIS PHARMACEUTICALS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 88 Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 92 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA U.S.A. PATRIOT Act 89 93 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2September 23, 2017 2019, between Flexion Therapeutics, Inc.ADESTO TECHNOLOGIES CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 78 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 80 Section 17.01. Provisions Binding on Company’s Successors 84 80 Section 17.02. Official Acts by Successor Corporation 84 80 Section 17.03. Addresses for Notices, Etc. 84 81 Section 17.04. Governing Law; Jurisdiction 85 Law 81 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 81 Section 17.06. Legal Holidays 86 82 Section 17.07. No Security Interest Created 86 82 Section 17.08. Benefits of Indenture 86 82 Section 17.09. Table of Contents, Headings, Etc. 87 82 Section 17.10. Authenticating Agent 87 82 Section 17.11. Execution in Counterparts 88 83 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 84 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 Exhibit A Form of Note A-1 84 INDENTURE dated as of May 2August 13, 2017 2012 between Flexion TherapeuticsIsis Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.0316.03 . Payment of Notes Called for Redemption 83 88 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 89 Section 17.0116.05 . Increased Conversion Rate Applicable to Certain Notes Surrendered in Connection with an Optional Redemption 89 Section 17.01 . Provisions Binding on Company’s Successors 84 89 Section 17.0217.02 . Official Acts by Successor Corporation 84 90 Section 17.0317.03 . Addresses for Notices, Etc. 84 90 Section 17.0417.04 . Governing Law; Jurisdiction 85 90 Section 17.0517.05 . Service of Process 91 Section 17.06 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.0617.07 . Legal Holidays 86 92 Section 17.0717.08 . No Security Interest Created 86 92 Section 17.0817.09 . Benefits of Indenture 86 92 Section 17.0917.10 . Table of Contents, Headings, Etc. 87 92 Section 17.1017.11 . Authenticating Agent 87 92 Section 17.1117.12 . Execution in Counterparts 88 93 Section 17.1217.13 . Severability 88 94 Section 17.1317.14 . Waiver of Jury Trial 88 94 Section 17.1417.15 . Force Majeure 88 94 Section 17.1517.16 . Calculations 88 94 Section 17.1617.17 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 94 Section 17.18 . Electronic Communication 94 INDENTURE dated as of May 2December 17, 2017 2013 between Flexion Therapeutics, Inc.YANDEX N.V., a Delaware corporationpublic company with limited liability (naamloze vennootschap) incorporated under Dutch law, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationTHE BANK OF NEW YORK MELLON, a national New York banking association organized under the laws of the United States of Americacorporation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 86 Section 16.0316.03 . Payment of Notes Called for Redemption 83 88 Section 16.0416.04 . Restrictions on Redemption 84 88 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 88 Section 17.0217.02 . Official Acts by Successor Corporation 84 88 Section 17.0317.03 . Addresses for Notices, Etc. 84 88 Section 17.0417.04 . Governing Law; Jurisdiction 85 89 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.0617.06 . Legal Holidays 86 90 Section 17.0717.07 . No Security Interest Created 86 91 Section 17.0817.08 . Benefits of Indenture 86 91 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 91 Section 17.1017.10 . Authenticating Agent 87 91 Section 17.1117.11 . Execution in Counterparts 88 92 Section 17.1217.12 . Severability 88 92 Section 17.1317.13 . Waiver of Jury Trial 88 92 Section 17.1417.14 . Force Majeure 88 92 Section 17.1517.15 . Calculations 88 93 Section 17.1617.16 . USA U.S.A. PATRIOT Act 89 93 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2March 12, 2017 2021, between Flexion TherapeuticsVOCERA COMMUNICATIONS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 91 Section 16.03. Payment of Notes Called for Redemption 83 92 Section 16.04. Restrictions on Redemption 84 93 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 93 Section 17.02. Official Acts by Successor Corporation 84 93 Section 17.03. Addresses for Notices, Etc. 84 93 Section 17.04. Governing Law; Jurisdiction 85 94 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 94 Section 17.06. Legal Holidays 86 95 Section 17.07. No Security Interest Created 86 95 Section 17.08. Benefits of Indenture 86 95 Section 17.09. Table of Contents, Headings, Etc. 87 95 Section 17.10. Authenticating Agent 87 95 Section 17.11. Execution in Counterparts 88 96 Section 17.12. Severability 88 97 Section 17.13. Waiver of Jury Trial 88 97 Section 17.14. Force Majeure 88 97 Section 17.15. Calculations 88 98 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 98 Section 17.17. Tax Withholding 98 INDENTURE dated as of May 2December 6, 2017 2024 between Flexion TherapeuticsBILL HOLDINGS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankComputershare Trust Company, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 91 Section 16.03. Payment of Notes Called for Redemption 83 92 Section 16.04. Restrictions on Redemption 84 93 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 93 Section 17.02. Official Acts by Successor Corporation 84 Entity 93 Section 17.03. Addresses for Notices, Etc. 84 93 Section 17.04. Governing Law; Jurisdiction 85 Law 94 Section 17.05. Intentionally Omitted 94 Section 17.06. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 94 Section 17.0617.07. Legal Holidays 86 95 Section 17.0717.08. No Security Interest Created 86 95 Section 17.0817.09. Benefits of Indenture 86 95 Section 17.0917.10. Table of Contents, Headings, Etc. 87 95 Section 17.1017.11. Authenticating Agent 87 95 Section 17.1117.12. Execution in Counterparts 88 96 Section 17.1217.13. Severability 88 97 Section 17.1317.14. Waiver of Jury Trial 88 97 Section 17.1417.15. Force Majeure 88 Section 17.15. Calculations 88 97 Section 17.16. USA PATRIOT Calculations 97 Section 17.17. U.S.A. Patriot Act 89 97 Section 17.18. FATCA 98 Exhibit A Form of Note A-1 INDENTURE Exhibit B Form of Free Transferability Certificate B-1 INDENTURE, dated as of May 2June 6, 2017 2022, between Flexion Therapeutics, Inc.CONMED Corporation, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo BankU.S. Bank Trust Company, National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 85 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 85 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 86 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 87 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 88 Section 17.10. Authenticating Agent 87 88 Section 17.11. Execution in Counterparts 88 89 Section 17.12. Severability 88 89 Section 17.13. Waiver of Jury Trial 88 89 Section 17.14. Force Majeure 88 89 Section 17.15. Calculations 88 89 Section 17.16. USA U.S.A. PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE 90 Section 17.17. Withholding Taxes 90 Section 17.18. Electronic Signatures 90 INDENTURE, dated as of May 21, 2017 2020, between Flexion TherapeuticsRAPID7, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 84 Section 16.03. Payment of Notes Called for Redemption 83 85 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 86 Section 17.01. Provisions Binding on Company’s Successors 84 86 Section 17.02. Official Acts by Successor Corporation 84 86 Section 17.03. Addresses for Notices, Etc. 84 86 Section 17.04. Governing Law; Jurisdiction 85 87 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 87 Section 17.06. Legal Holidays 86 88 Section 17.07. No Security Interest Created 86 88 Section 17.08. Benefits of Indenture 86 88 Section 17.09. Table of Contents, Headings, Etc. 87 89 Section 17.10. Authenticating Agent 87 89 Section 17.11. Execution in Counterparts 88 90 Section 17.12. Severability 88 90 Section 17.13. Waiver of Jury Trial 88 90 Section 17.14. Force Majeure 88 90 Section 17.15. Calculations 88 90 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 91 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2June 28, 2017 2018, between Flexion TherapeuticsMONGODB, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 81 Section 16.03. Payment of Notes Called for Redemption 83 82 Section 16.04. Restrictions on Redemption 84 82 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 83 Section 17.02. Official Acts by Successor Corporation 84 83 Section 17.03. Addresses for Notices, Etc. 84 Etc 83 Section 17.04. Governing Law; Jurisdiction 85 84 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 84 Section 17.06. Legal Holidays 86 85 Section 17.07. No Security Interest Created 86 85 Section 17.08. Benefits of Indenture 86 85 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 85 Section 17.10. Authenticating Agent 87 85 Section 17.11. Execution in Counterparts 88 86 Section 17.12. Severability 88 86 Section 17.13. Waiver of Jury Trial 88 86 Section 17.14. Force Majeure 88 87 Section 17.15. Calculations 88 87 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 87 Section 17.17. Foreign Account Tax Compliance Act (FATCA) 87 INDENTURE dated as of May 2August 21, 2017 2018 between Flexion TherapeuticsIllumina, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankThe Bank of New York Mellon Trust Company, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 90 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 90 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.06. Legal Holidays 86 92 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 94 Section 17.12. Severability 88 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 94 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 95 Section 17.17. Tax Withholding. 95 INDENTURE dated as of May 2December 11, 2017 2020 between Flexion Therapeutics, Inc.MICROSTRATEGY INCORPORATED, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 79 Section 16.0316.03 . Payment of Notes Called for Redemption 83 81 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 81 Section 17.0117.01 . Provisions Binding on Company’s Successors 84 81 Section 17.0217.02 . Official Acts by Successor Corporation 84 81 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 82 Section 17.0417.04 . Governing Law; Jurisdiction 85 82 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 83 Section 17.0617.06 . Legal Holidays 86 83 Section 17.0717.07 . No Security Interest Created 86 83 Section 17.0817.08 . Benefits of Indenture 86 83 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 83 Section 17.1017.10 . Authenticating Agent 87 84 Section 17.1117.11 . Execution in Counterparts 88 84 Section 17.1217.12 . Severability 88 85 Section 17.1317.13 . Waiver of Jury Trial 88 85 Section 17.1417.14 . Force Majeure 88 85 Section 17.1517.15 . Calculations 88 85 Section 17.1617.16 . USA PATRIOT Act 89 85 Section 17.17 . Tax Withholding 86 Exhibit A Form of Note A-1 INDENTURE dated as of May 2February 27, 2017 2024 between Flexion TherapeuticsLYFT, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 91 Section 16.03. Payment of Notes Called for Redemption 83 93 Section 16.04. Restrictions on Redemption 84 93 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 93 Section 17.02. Official Acts by Successor Corporation 84 93 Section 17.03. Addresses for Notices, Etc. 84 94 Section 17.04. Governing Law; Jurisdiction 85 94 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 95 Section 17.06. Legal Holidays 86 96 Section 17.07. No Security Interest Created 86 96 Section 17.08. Benefits of Indenture 86 96 Section 17.09. Table of Contents, Headings, Etc. 87 96 Section 17.10. Authenticating Agent 87 96 Section 17.11. Execution in Counterparts 88 97 Section 17.12. Severability 88 97 Section 17.13. Waiver of Jury Trial 88 98 Section 17.14. Force Majeure 88 98 Section 17.15. Calculations 88 98 Section 17.16. USA PATRIOT Act 89 98 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 16, 2017 2020 between Flexion TherapeuticsWISDOMTREE INVESTMENTS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 96 Section 16.03. Payment of Notes Called for Redemption 83 98 Section 16.04. Restrictions on Redemption 84 98 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 98 Section 17.02. Official Acts by Successor Corporation 84 Entity 99 Section 17.03. Addresses for Notices, Etc. 84 99 Section 17.04. Governing Law; Jurisdiction 85 Law 100 Section 17.05. Intentionally Omitted 100 Section 17.06. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 100 Section 17.0617.07. Legal Holidays 86 100 Section 17.0717.08. No Security Interest Created 86 101 Section 17.0817.09. Benefits of Indenture 86 101 Section 17.0917.10. Table of Contents, Headings, Etc. 87 101 Section 17.1017.11. Authenticating Agent 87 101 Section 17.1117.12. Execution in Counterparts 88 Counterparts; Electronic Signatures 102 Section 17.1217.13. Severability 88 103 Section 17.1317.14. Waiver of Jury Trial 88 Trial; Submission of Jurisdiction 103 Section 17.1417.15. Force Majeure 88 Section 17.15. Calculations 88 103 Section 17.16. USA PATRIOT Act 89 Calculations 103 Section 17.17. Tax Withholding and Reporting 104 Exhibit A Form of Note A-1 Exhibit B Form of Supplemental Indenture B-1 INDENTURE dated as of May 2February 28, 2017 between Flexion Therapeutics, Inc.2023 among ON Semiconductor Corporation, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) ), the Guarantors listed on the signature page hereof, and ▇▇▇▇▇ Fargo BankComputershare Trust Company, National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.03. Payment of Notes Called for Redemption 83 90 Section 16.04. Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 91 Section 17.02. Official Acts by Successor Corporation 84 91 Section 17.03. Addresses for Notices, Etc. 84 91 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 94 Section 17.10. Authenticating Agent 87 94 Section 17.11. Execution in Counterparts 88 95 Section 17.12. Severability 88 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 96 Section 17.17. Tax Withholding 96 INDENTURE dated as of May 2November 21, 2017 2024 between Flexion Therapeutics, Inc.MICROSTRATEGY INCORPORATED, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. 84 Etc 85 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 86 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2March 4, 2017 2014 between Flexion Therapeutics, UTi Worldwide Inc., a Delaware corporationBritish Virgin Islands company, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 74 Section 16.03. Payment of Notes Called for Redemption 83 75 Section 16.04. Restrictions on Redemption 84 75 Section 16.05. Increase In Conversion Rate Upon Conversion During a Redemption Period 76 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 76 Section 17.02. Official Acts by Successor Corporation 84 76 Section 17.03. Addresses for Notices, Etc. 84 Etc 76 Section 17.04. Governing Law; Jurisdiction 85 77 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 78 Section 17.06. Legal Holidays 86 78 Section 17.07. No Security Interest Created 86 78 Section 17.08. Benefits of Indenture 86 78 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 78 Section 17.10. Authenticating Agent 87 79 Section 17.11. Execution in Counterparts 88 80 Section 17.12. Severability 88 80 Section 17.13. Waiver of Jury Trial 88 80 Section 17.14. Force Majeure 88 80 Section 17.15. Calculations 88 80 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 80 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2June 1, 2017 2018 between Flexion TherapeuticsPANDORA MEDIA, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankCITIBANK, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 81 Section 16.03. Payment of Notes Called for Redemption 83 Section 16.04. Restrictions on Redemption 84 83 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 83 Section 17.02. Official Acts by Successor Corporation 84 83 Section 17.03. Addresses for Notices, Etc. 84 Etc 83 Section 17.04. Governing Law; Jurisdiction 85 84 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 85 Section 17.06. Legal Holidays 86 85 Section 17.07. No Security Interest Created 86 85 Section 17.08. Benefits of Indenture 86 85 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 85 Section 17.10. Authenticating Agent 87 86 Section 17.11. Execution in Counterparts 88 87 Section 17.12. Severability 88 87 Section 17.13. Waiver of Jury Trial 88 87 Section 17.14. Force Majeure 88 87 Section 17.15. Calculations 88 87 Section 17.16. USA PATRIOT Act 89 88 Exhibit A Form of Note A-1 INDENTURE dated as of May 2August 24, 2017 2018 between Flexion TherapeuticsMercadoLibre, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWilmington Trust, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 78 Section 16.03. Payment of Notes Called for Redemption 83 79 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 79 Article 17 Miscellaneous Provisions Section 17.01. Provisions Binding on Company’s Successors 84 80 Section 17.02. Official Acts by Successor Corporation 84 80 Section 17.03. Addresses for Notices, Etc. 84 Etc 80 Section 17.04. Governing Law; Jurisdiction 85 81 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 81 Section 17.06. Legal Holidays 86 82 Section 17.07. No Security Interest Created 86 82 Section 17.08. Benefits of Indenture 86 82 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 82 Section 17.10. Authenticating Agent 87 82 Section 17.11. Execution in Counterparts 88 83 Section 17.12. Severability 88 83 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 84 Section 17.16. USA PATRIOT Act 89 84 Section 17.17. Foreign Account Tax Compliance Act (FATCA) 84 Exhibit A Form of Note A-1 INDENTURE dated as of May 2December 14, 2017 2016 between Flexion TherapeuticsAEROJET ROCKETDYNE HOLDINGS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankTHE BANK OF NEW YORK MELLON TRUST COMPANY, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 78 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 80 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 80 Section 17.02. Official Acts by Successor Corporation 84 80 Section 17.03. Addresses for Notices, Etc. 84 Etc 81 Section 17.04. Governing Law; Jurisdiction 85 81 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.06. Legal Holidays 86 82 Section 17.07. No Security Interest Created 86 82 Section 17.08. Benefits of Indenture 86 82 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 83 Section 17.10. Authenticating Agent 87 83 Section 17.11. Execution in Counterparts 88 84 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 84 Section 17.16. USA PATRIOT Act 89 85 Exhibit A Form of Note A-1 INDENTURE dated as of May 2March 26, 2017 2021 between Flexion Therapeutics, Inc.MP MATERIALS CORP., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 90 Section 16.03. Payment of Notes Called for Redemption 83 91 Section 16.04. Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 92 Section 17.02. Official Acts by Successor Corporation 84 92 Section 17.03. Addresses for Notices, Etc. 84 92 Section 17.04. Governing Law; Jurisdiction 85 93 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.06. Legal Holidays 86 94 Section 17.07. No Security Interest Created 86 94 Section 17.08. Benefits of Indenture 86 94 Section 17.09. Table of Contents, Headings, Etc. 87 94 Section 17.10. Authenticating Agent 87 94 Section 17.11. Execution in Counterparts 88 95 Section 17.12. Severability 88 Severability; Entire Agreement 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 96 Section 17.16. USA PATRIOT Act 89 96 Section 17.17. Tax Withholding 96 Section 17.18. Electronic Signatures 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 16, 2017 2020 between Flexion TherapeuticsZENDESK, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 Section 16.04. Restrictions on Redemption 84 83 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. Etc 84 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 85 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 86 Section 17.10. Authenticating Agent 87 86 Section 17.11. Execution in Counterparts 88 87 Section 17.12. Severability 88 87 Section 17.13. Waiver of Jury Trial 88 87 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 Exhibit A Form of Note A-1 INDENTURE 88 INDENTURE, dated as of May 2November 17, 2017 2017, between Flexion Therapeutics, Inc.QUOTIENT TECHNOLOGY INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Statements Required in Certificate or Opinion 91 Section 17.07. Legal Holidays 86 91 Section 17.0717.08. No Security Interest Created 86 91 Section 17.0817.09. Benefits of Indenture 86 91 Section 17.0917.10. Table of Contents, Headings, Etc. 87 Etc 91 Section 17.1017.11. Authenticating Agent 87 92 Section 17.1117.12. Execution in Counterparts 88 93 Section 17.1217.13. Severability 88 93 Section 17.1317.14. Waiver of Jury Trial 88 93 Section 17.1417.15. Force Majeure 88 93 Section 17.1517.16. Calculations 88 93 Section 17.1617.17. USA PATRIOT Act 89 Exhibit A Form of Note A-1 94 INDENTURE dated as of May 2June 23, 2017 2020 between Flexion TherapeuticsCryoLife, Inc., a Delaware Florida corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, U.S. Bank National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 84 Section 16.03. Payment of Notes Called for Redemption 83 85 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 86 ARTICLE 17 Miscellaneous Provisions Section 17.01. Provisions Binding on Company’s Successors 84 86 Section 17.02. Official Acts by Successor Corporation 84 86 Section 17.03. Addresses for Notices, Etc. 84 86 Section 17.04. Governing Law; Jurisdiction 85 87 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 87 Section 17.06. Statements Required in Certificate or Opinion. 88 Section 17.07. Legal Holidays 86 88 Section 17.0717.08. No Security Interest Created 86 88 Section 17.0817.09. Benefits of Indenture 86 89 Section 17.0917.10. Table of Contents, Headings, Etc. 87 89 Section 17.1017.11. Authenticating Agent 87 89 Section 17.1117.12. Execution in Counterparts 88 Counterparts; PDF Transmission 90 Section 17.1217.13. Severability 88 90 Section 17.1317.14. Waiver of Jury Trial 88 90 Section 17.1417.15. Force Majeure 88 Section 17.15. Calculations 88 90 Section 17.16. Calculations 90 Section 17.17. USA PATRIOT Patriot Act 89 Exhibit A Form of Note A-1 91 INDENTURE dated as of May 2September 20, 2017 2019 between Flexion TherapeuticsPTC THERAPEUTICS, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 90 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 90 ARTICLE 17 Miscellaneous Provisions Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 Counterparts; Electronic Signatures 94 Section 17.12. Severability 88 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 96 Section 17.17. Tax Withholding 96 Section 17.18. Service of Process 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2July 8, 2017 2024 between Flexion Therapeutics, Inc.REPAY HOLDINGS CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 88 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 89 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 93 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT Act 89 93 Section 17.17. Withholding Taxes 94 Exhibit A Form of Note A-1 INDENTURE dated as of May 2February 26, 2017 2024 between Flexion Therapeutics, Inc.▇▇▇▇▇▇▇ CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 94 Section 16.0316.03 . Payment of Notes Called for Redemption 83 96 Section 16.04. 16.04 Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 96 ARTICLE 17 Miscellaneous Provisions Section 17.0117.01 . Provisions Binding on Company’s Successors 84 96 Section 17.0217.02 . Official Acts by Successor Corporation 84 96 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 97 Section 17.0417.04 . Governing Law; Jurisdiction 85 97 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 98 Section 17.0617.06 . Legal Holidays 86 99 Section 17.0717.07 . No Security Interest Created 86 99 Section 17.0817.08 . Benefits of Indenture 86 99 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 99 Section 17.1017.10 . Authenticating Agent 87 99 Section 17.1117.11 . Execution in Counterparts 88 100 Section 17.1217.12 . Severability 88 101 Section 17.1317.13 . Waiver of Jury Trial 88 101 Section 17.1417.14 . Force Majeure 88 101 Section 17.1517.15 . Calculations 88 101 Section 17.1617.16 . USA PATRIOT Act 89 102 Section 17.17 . Tax Withholding 102 Exhibit A Form of Note A-1 INDENTURE dated as of May 2September 8, 2017 2025 between Flexion TherapeuticsIMPINJ, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. 84 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 85 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 Section 17.09. Table of Contents, Headings, Etc. 87 86 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2September 10, 2017 2019 between Flexion Therapeutics, Inc.INVITAE CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. 84 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2September 18, 2017 2018 between Flexion TherapeuticsDOCUSIGN, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 81 Section 16.03. Payment of Notes Called for Redemption 83 82 Section 16.04. Restrictions on Redemption 84 83 Section 16.05. Increase in Conversion Rate upon Conversion During a Redemption Period 83 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 83 Section 17.02. Official Acts by Successor Corporation 84 83 Section 17.03. Addresses for Notices, Etc. 84 Etc 83 Section 17.04. Governing Law; Jurisdiction 85 84 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 84 Section 17.06. Legal Holidays 86 85 Section 17.07. No Security Interest Created 86 85 Section 17.08. Benefits of Indenture 86 85 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 85 Section 17.10. Authenticating Agent 87 85 Section 17.11. Execution in Counterparts 88 86 Section 17.12. Severability 88 87 Section 17.13. Waiver of Jury Trial 88 87 Section 17.14. Force Majeure 88 87 Section 17.15. Calculations 88 87 Section 17.16. USA PATRIOT Act 89 87 Exhibit A Form of Note A-1 INDENTURE dated as of May 2September 15, 2017 2015 between Flexion TherapeuticsBROADSOFT, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇W▇▇▇▇ Fargo BankFARGO BANK, National AssociationNATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of AmericaStates, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 83 Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. Etc 84 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 85 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 Section 17.08. Benefits of Indenture 86 Section 17.09. Table of Contents, Headings, Etc. 87 86 Section 17.10. Authenticating Agent 87 86 Section 17.11. Execution in Counterparts 88 87 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2November 23, 2017 2021 between Flexion TherapeuticsAFFIRM HOLDINGS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo BankWilmington Trust, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 80 Section 16.03. Payment of Notes Called for Redemption 83 81 Section 16.04. Restrictions on Redemption 84 82 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 82 Section 17.02. Official Acts by Successor Corporation 84 82 Section 17.03. Addresses for Notices, Etc. 84 82 Section 17.04. Governing Law; Jurisdiction 85 83 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 84 Section 17.06. Legal Holidays 86 84 Section 17.07. No Security Interest Created 86 84 Section 17.08. Benefits of Indenture 86 84 Section 17.09. Table of Contents, Headings, Etc. 87 84 Section 17.10. Authenticating Agent 87 85 Section 17.11. Execution in Counterparts 88 86 Section 17.12. Severability 88 86 Section 17.13. Waiver of Jury Trial 88 86 Section 17.14. Force Majeure 88 86 Section 17.15. Calculations 88 86 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 87 Section 17.17. Foreign Account Tax Compliance Act (FATCA) 87 INDENTURE dated as of May 2December 12, 2017 2016 between Flexion TherapeuticsZillow Group, Inc., a Delaware Washington corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankThe Bank of New York Mellon Trust Company, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 79 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 81 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 81 Section 17.02. Official Acts by Successor Corporation 84 81 Section 17.03. Addresses for Notices, Etc. 84 Etc 81 Section 17.04. Governing Law; Jurisdiction 85 82 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.06. Legal Holidays 86 83 Section 17.07. No Security Interest Created 86 83 Section 17.08. Benefits of Indenture 86 83 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 83 Section 17.10. Authenticating Agent 87 83 Section 17.11. Execution in Counterparts 88 84 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 85 Section 17.14. Force Majeure 88 85 Section 17.15. Calculations 88 85 Section 17.16. USA PATRIOT Act 89 85 Exhibit A Form of Note A-1 INDENTURE dated as of May 2December 27, 2017 2018 between Flexion TherapeuticsBENEFITFOCUS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 81 Section 16.03. Payment of Notes Called for Redemption 83 82 Section 16.04. Restrictions on Redemption 84 83 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 83 Section 17.02. Official Acts by Successor Corporation 84 83 Section 17.03. Addresses for Notices, Etc. 84 Etc 83 Section 17.04. Governing Law; Jurisdiction 85 84 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 84 Section 17.06. Legal Holidays 86 85 Section 17.07. No Security Interest Created 86 85 Section 17.08. Benefits of Indenture 86 85 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 85 Section 17.10. Authenticating Agent 87 85 Section 17.11. Execution in Counterparts 88 86 Section 17.12. Severability 88 87 Section 17.13. Waiver of Jury Trial 88 87 Section 17.14. Force Majeure 88 87 Section 17.15. Calculations 88 87 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 Exhibit A Form of Note A-1 INDENTURE 87 INDENTURE, dated as of May 2January 17, 2017 2018, between Flexion Therapeutics, Inc.COUPA SOFTWARE INCORPORATED, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 Person 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 92 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT Act 89 93 Section 17.17. Withholding Taxes 93 Exhibit A Form of Note A-1 Exhibit B Form of Free Transferability Certificate B-1 INDENTURE dated as of May 2November 19, 2017 2018 between Flexion Therapeutics, Inc.WAYFAIR INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).. In order to declare the terms and conditions upon which the Company’s 1.125% Convertible Senior Notes due 2024 (the “Notes”) are, and are to be, authenticated, issued and delivered, and in consideration of the premises and of the purchase and acceptance of the Notes by the Holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective Holders from time to time of the Notes (except as otherwise provided below), as follows:

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.03. Payment of Notes Called for Redemption 83 90 Section 16.04. Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 91 Section 17.02. Official Acts by Successor Corporation 84 91 Section 17.03. Addresses for Notices, Etc. 84 Etc 91 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 94 Section 17.12. Severability 88 Severability; Entire Agreement 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 96 Section 17.17. Tax Withholding 96 Section 17.18. Electronic Signatures 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 4, 2017 2020 between Flexion TherapeuticsHUBSPOT, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.0316.03 . Payment of Notes Called for Redemption 83 84 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 Section 17.0217.02 . Official Acts by Successor Corporation 84 Section 17.0317.03 . Addresses for Notices, Etc. Etc 84 Section 17.0417.04 . Governing Law; Jurisdiction 85 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.0617.06 . Legal Holidays 86 Section 17.0717.07 . No Security Interest Created 86 Section 17.0817.08 . Benefits of Indenture 86 Section 17.0917.09 . Table of Contents, Headings, Etc. Etc 87 Section 17.1017.10 . Authenticating Agent 87 Section 17.1117.11 . Execution in Counterparts 88 Section 17.1217.12 . Severability 88 Section 17.1317.13 . Waiver of Jury Trial 88 Section 17.1417.14 . Force Majeure 88 Section 17.1517.15 . Calculations 88 Section 17.1617.16 . USA U.S.A. PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2September 17, 2017 2019, between Flexion Therapeutics, Inc.HESKA CORPORATION, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section ‎Section 1.01) ), and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 79 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 81 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 81 Section 17.02. Official Acts by Successor Corporation 84 81 Section 17.03. Addresses for Notices, Etc. 84 81 Section 17.04. Governing Law; Jurisdiction 85 82 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.06. Legal Holidays 86 83 Section 17.07. No Security Interest Created 86 83 Section 17.08. Benefits of Indenture 86 83 Section 17.09. Table of Contents, Headings, Etc. 87 83 Section 17.10. Authenticating Agent 87 83 Section 17.11. Execution in Counterparts 88 84 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 85 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 85 INDENTURE dated as of May 2June 26, 2017 between Flexion Therapeutics, Inc.SYNAPTICS INCORPORATED, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankFARGO BANK, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 92 Section 16.0316.03 . Payment of Notes Called for Redemption 83 93 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS 94 ARTICLE 17MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 94 Section 17.0217.02 . Official Acts by Successor Corporation 84 Entity 94 Section 17.0317.03 . Addresses for Notices, Etc. 84 94 Section 17.0417.04 . Governing Law; Jurisdiction 85 95 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 95 Section 17.0617.06 . Legal Holidays 86 96 Section 17.0717.07 . No Security Interest Created 86 96 Section 17.0817.08 . Benefits of Indenture 86 96 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 97 Section 17.1017.10 . Authenticating Agent 87 97 Section 17.1117.11 . Execution in Counterparts 88 98 Section 17.1217.12 . Severability 88 98 Section 17.1317.13 . Waiver of Jury Trial 88 98 Section 17.1417.14 . Force Majeure 88 98 Section 17.1517.15 . Calculations 88 98 Section 17.1617.16 . USA PATRIOT Act 89 99 Section 17.17 . Electronic Signatures 99 Exhibit A Form of Note A-1 INDENTURE dated as of May 2July 22, 2017 2025 between Flexion Therapeutics, Inc.BLACKSKY TECHNOLOGY INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS 88 ARTICLE 17MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 Etc 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 93 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 Calculations. 93 Section 17.16. USA PATRIOT Act 89 93 Exhibit A Form of Note A-1 INDENTURE dated as of May 2April 9, 2017 2021 between Flexion Therapeutics, Inc.Century Aluminum Company, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWilmington Trust, National Association, a national banking association organized under the laws of the United States of AmericaStates, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 90 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.06. Legal Holidays 86 92 Section 17.07. No Security Interest Created 86 92 Section 17.08. Benefits of Indenture 86 92 Section 17.09. Table of Contents, Headings, Etc. 87 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 94 Section 17.12. Severability 88 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 94 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 95 Section 17.17. Electronic Signatures 95 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2September 9, 2017 2025, between Flexion Therapeutics, Inc.JBT MAREL CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of AmericaStates, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.0316.03 . Payment of Notes Called for Redemption 83 88 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 88 Section 17.0117.01 . Provisions Binding on Company’s Successors 84 89 Section 17.0217.02 . Official Acts by Successor Corporation 84 89 Section 17.0317.03 . Addresses for Notices, Etc. 84 89 Section 17.0417.04 . Governing Law; Jurisdiction 85 90 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.0617.06 . Legal Holidays 86 91 Section 17.0717.07 . No Security Interest Created 86 91 Section 17.0817.08 . Benefits of Indenture 86 91 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 91 Section 17.1017.10 . Authenticating Agent 87 91 Section 17.1117.11 . Execution in Counterparts 88 92 Section 17.1217.12 . Severability 88 93 Section 17.1317.13 . Waiver of Jury Trial 88 93 Section 17.1417.14 . Force Majeure 88 93 Section 17.1517.15 . Calculations 88 93 Section 17.1617.16 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 93 Section 17.17 . Electronic Signatures 94 INDENTURE dated as of May 2September 25, 2017 2020 between Flexion TherapeuticsOMNICELL, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 81 Section 16.03. Payment of Notes Called for Redemption 83 82 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 83 Section 17.01. Provisions Binding on Company’s Successors 84 83 Section 17.02. Official Acts by Successor Corporation 84 83 Section 17.03. Addresses for Notices, Etc. 84 83 Section 17.04. Governing Law; Jurisdiction 85 84 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 84 Section 17.06. Legal Holidays 86 85 Section 17.07. No Security Interest Created 86 85 Section 17.08. Benefits of Indenture 86 85 Section 17.09. Table of Contents, Headings, Etc. 87 85 Section 17.10. Authenticating Agent 87 85 Section 17.11. Execution in Counterparts 88 86 Section 17.12. Severability 88 86 Section 17.13. Waiver of Jury Trial 88 86 Section 17.14. Force Majeure 88 87 Section 17.15. Calculations 88 87 Section 17.16. USA PATRIOT Act 89 87 Exhibit A Form of Note A-1 INDENTURE INDENTURE; dated as of May 2October 5, 2017 2018; between Flexion TherapeuticsBOINGO WIRELESS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National Association, a national banking association organized under the laws of the United States of AmericaNATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 90 Article 17 Miscellaneous Provisions Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.06. Legal Holidays 86 92 Section 17.07. No Security Interest Created 86 92 Section 17.08. Benefits of Indenture 86 92 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 Counterparts; Electronic Signatures 94 Section 17.12. Severability 88 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 94 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 95 Section 17.17. Tax Withholding 95 Section 17.18. Service of Process 95 Exhibit A Form of Note A-1 INDENTURE dated as of May 2February 3, 2017 2023 between Flexion Therapeutics, Inc.INTEGER HOLDINGS CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.03. Payment of Notes Called for Redemption 83 90 Section 16.04. Restrictions on Redemption 84 90 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 91 Section 17.02. Official Acts by Successor Corporation 84 91 Section 17.03. Addresses for Notices, Etc. 84 91 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 and Electronic Signing 94 Section 17.12. Severability 88 Severability; Entire Agreement 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 95 Section 17.17. Tax Withholding 95 Section 17.18. Electronic Signatures 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2December 17, 2017 2021 between Flexion TherapeuticsGLOBAL BLOOD THERAPEUTICS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 90 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 90 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.06. Legal Holidays 86 92 Section 17.07. No Security Interest Created 86 92 Section 17.08. Benefits of Indenture 86 92 Section 17.09. Table of Contents, Headings, Etc. 87 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 94 Section 17.12. Severability 88 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 94 Section 17.15. Calculations 88 95 Section 17.16. USA U.S.A. PATRIOT Act 89 95 Section 17.17. Withholding Taxes 95 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 227, 2017 2022, between Flexion TherapeuticsCUTERA, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 Entity 85 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 Law 86 Section 17.05. Intentionally Omitted 86 Section 17.06. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.0617.07. Legal Holidays 86 Section 17.0717.08. No Security Interest Created 86 87 Section 17.0817.09. Benefits of Indenture 86 87 Section 17.0917.10. Table of Contents, Headings, Etc. 87 Section 17.1017.11. Authenticating Agent 87 Section 17.1117.12. Execution in Counterparts 88 Section 17.1217.13. Severability 88 Section 17.1317.14. Waiver of Jury Trial 88 Section 17.14. Force Majeure Trial; Submission of Jurisdiction 88 Section 17.15. Calculations 88 Force Majeure 89 Section 17.16. USA PATRIOT Calculations 89 Section 17.17. U.S.A. Patriot Act 89 Section 17.18. Tax Withholding 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2April 4, 2017 between Flexion TherapeuticsCarbonite, Inc., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo Bank, U.S. Bank National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 88 ARTICLE 17 Miscellaneous Provisions 88 Section 17.01. Provisions Binding on Company’s Successors 84 88 Section 17.02. Official Acts by Successor Corporation 84 88 Section 17.03. Addresses for Notices, Etc. 84 Etc 89 Section 17.04. Governing Law; Jurisdiction 85 89 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 90 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 92 Section 17.13. Waiver of Jury Trial 88 92 Section 17.14. Force Majeure 88 92 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT Act 89 93 Section 17.17. Electronic Signatures 93 Exhibit A Form of Note A-1 INDENTURE dated as of May 2December 3, 2017 2024 between Flexion Therapeutics, Inc.ASTRONICS CORPORATION, a Delaware New York corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. Bank Trust Company, National Association, a national banking association organized under the laws of the United States of AmericaStates, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 72 Section 16.03. Payment of Notes Called for Redemption 83 73 Section 16.04. Restrictions on Redemption 84 74 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Indenture Subject to Trust Indenture Act 74 Section 17.02. Provisions Binding on Company’s Successors 84 74 Section 17.0217.03. Official Acts by Successor Corporation 84 74 Section 17.0317.04. Addresses for Notices, Etc. 84 74 Section 17.0417.05. Communication by Holders with Other Holders 75 Section 17.06. Governing Law; Jurisdiction 85 75 Section 17.0517.07. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 75 Section 17.0617.08. Legal Holidays 86 76 Section 17.07. No Security Interest Created 86 Section 17.0817.09. Benefits of Indenture 86 76 Section 17.0917.10. Table of Contents, Headings, Etc. 87 76 Section 17.1017.11. Authenticating Agent 87 76 Section 17.1117.12. Execution in Counterparts 88 77 Section 17.1217.13. Severability 88 77 Section 17.1317.14. Waiver of Jury Trial 88 78 Section 17.1417.15. Force Majeure 88 78 Section 17.1517.16. Calculations 88 78 Section 17.1617.17. USA PATRIOT Act 89 78 Exhibit A Form of Note A-1 Exhibit B Form of Collateral Trust Agreement B-1 Exhibit C Form of Intercreditor and Subordination Agreement C-1 INDENTURE dated as of May 2October [ ], 2017 between Flexion Therapeutics2016 among ▇▇▇▇▇▇▇▇▇ ENERGY, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), the GUARANTORS named in the signature pages hereto (each, a “Guarantor” and collectively, the “Guarantors,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 86 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 88 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 88 Section 17.02. Official Acts by Successor Corporation 84 88 Section 17.03. Addresses for Notices, Etc. 84 88 Section 17.04. Governing Law; Jurisdiction 85 89 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 90 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 92 Section 17.13. Waiver of Jury Trial 88 92 Section 17.14. Force Majeure 88 92 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 93 Section 17.17. Electronic Signatures 93 INDENTURE dated as of May 2December 3, 2017 2021 between Flexion TherapeuticsARRAY TECHNOLOGIES, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.06. Statements Required in Certificate or Opinion 91 Section 17.07. Legal Holidays 86 91 Section 17.0717.08. No Security Interest Created 86 91 Section 17.0817.09. Benefits of Indenture 86 92 Section 17.0917.10. Table of Contents, Headings, Etc. 87 Etc 92 Section 17.1017.11. Authenticating Agent 87 92 Section 17.1117.12. Execution in Counterparts 88 93 Section 17.1217.13. Severability 88 93 Section 17.1317.14. Waiver of Jury Trial 88 93 Section 17.1417.15. Force Majeure 88 93 Section 17.1517.16. Calculations 88 94 Section 17.1617.17. USA PATRIOT Act 89 Exhibit A Form of Note A-1 94 INDENTURE dated as of May 214, 2017 2020 between Flexion Therapeutics, Inc.Pioneer Natural Resources Company, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 81 Section 16.0316.03 . Payment of Notes Called for Redemption 83 82 Section 16.0416.04 . Restrictions on Redemption 84 83 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 83 Section 17.0217.02 . Official Acts by Successor Corporation 84 83 Section 17.0317.03 . Addresses for Notices, Etc. 84 83 Section 17.0417.04 . Governing Law; Jurisdiction 85 84 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 84 Section 17.0617.06 . Legal Holidays 86 85 Section 17.0717.07 . No Security Interest Created 86 85 Section 17.0817.08 . Benefits of Indenture 86 85 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 85 Section 17.1017.10 . Authenticating Agent 87 85 Section 17.1117.11 . Execution in Counterparts 88 86 Section 17.1217.12 . Severability 88 87 Section 17.1317.13 . Waiver of Jury Trial 88 87 Section 17.1417.14 . Force Majeure 88 87 Section 17.1517.15 . Calculations 88 87 Section 17.1617.16 . USA U.S.A. PATRIOT Act 89 87 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2June 11, 2017 2019, between Flexion Therapeutics, Inc.COUPA SOFTWARE INCORPORATED, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.0316.03 . Payment of Notes Called for Redemption 83 84 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 Section 17.0217.02 . Official Acts by Successor Corporation 84 Section 17.0317.03 . Addresses for Notices, Etc. 84 85 Section 17.0417.04 . Governing Law; Jurisdiction 85 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.0617.06 . Legal Holidays 86 87 Section 17.0717.07 . No Security Interest Created 86 87 Section 17.0817.08 . Benefits of Indenture 86 87 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Section 17.1017.10 . Authenticating Agent 87 Section 17.1117.11 . Execution in Counterparts 88 Section 17.1217.12 . Severability 88 Section 17.1317.13 . Waiver of Jury Trial 88 Section 17.1417.14 . Force Majeure 88 Section 17.1517.15 . Calculations 88 89 Section 17.1617.16 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2February 14, 2017 2020 between Flexion TherapeuticsREVANCE THERAPEUTICS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.03. Payment of Notes Called for Redemption 83 90 Section 16.04. Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 91 Section 17.02. Official Acts by Successor Corporation 84 91 Section 17.03. Addresses for Notices, Etc. 84 Etc 91 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 94 Section 17.10. Authenticating Agent 87 94 Section 17.11. Execution in Counterparts 88 95 Section 17.12. Severability 88 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 96 Section 17.17. Tax Withholding 96 INDENTURE dated as of May 2June 17, 2017 2024 between Flexion Therapeutics, Inc.MICROSTRATEGY INCORPORATED, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 Section 17.02. Official Acts by Successor Corporation 84 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 Section 17.11. Execution in Counterparts 88 Section 17.12. Severability 88 Section 17.13. Waiver of Jury Trial 88 Section 17.14. Force Majeure 88 89 Section 17.15. Calculations 88 89 Section 17.16. USA U.S.A. PATRIOT Act 89 Section 17.17. No Personal Liability of Directors, Officers, Employees or Stockholders 89 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2August 21, 2017 2020, between Flexion Therapeutics, Inc.THE MIDDLEBY CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.0316.03 . Payment of Notes Called for Redemption 83 85 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 85 Article 17 Miscellaneous Provisions Section 17.0117.01 . Provisions Binding on Company’s Successors 84 85 Section 17.0217.02 . Official Acts by Successor Corporation 84 85 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 85 Section 17.0417.04 . Governing Law; Jurisdiction 85 86 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 87 Section 17.0617.06 . Legal Holidays 86 87 Section 17.0717.07 . No Security Interest Created 86 87 Section 17.0817.08 . Benefits of Indenture 86 88 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 88 Section 17.1017.10 . Authenticating Agent 87 88 Section 17.1117.11 . Execution in Counterparts 88 89 Section 17.1217.12 . Severability 88 89 Section 17.1317.13 . Waiver of Jury Trial 88 89 Section 17.1417.14 . Force Majeure 88 90 Section 17.1517.15 . Calculations 88 90 Section 17.1617.16 . USA U.S.A. PATRIOT Act 89 90 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2April 16, 2017 2020, between Flexion TherapeuticsN▇▇▇▇▇, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 90 Section 16.04. Restrictions on Redemption 84 90 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 91 Section 17.03. Addresses for Notices, Etc. 84 91 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.06. Legal Holidays 86 93 Section 17.07. No Security Interest Created 86 93 Section 17.08. Benefits of Indenture 86 93 Section 17.09. Table of Contents, Headings, Etc. 87 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 94 Section 17.12. Severability 88 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 95 Section 17.15. Calculations 88 95 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 95 INDENTURE dated as of May 2June 14, 2017 2021 between Flexion TherapeuticsWISDOMTREE INVESTMENTS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of AmericaU.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 86 Section 16.0316.03 . Payment of Notes Called for Redemption 83 88 Section 16.0416.04 . Restrictions on Redemption 84 88 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 88 Section 17.0217.02 . Official Acts by Successor Corporation 84 89 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 89 Section 17.0417.04 . Governing Law; Jurisdiction 85 89 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.0617.06 . Legal Holidays 86 91 Section 17.0717.07 . No Security Interest Created 86 91 Section 17.0817.08 . Benefits of Indenture 86 91 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 91 Section 17.1017.10 . Authenticating Agent 87 91 Section 17.1117.11 . Execution in Counterparts 88 92 Section 17.1217.12 . Severability 88 92 Section 17.1317.13 . Waiver of Jury Trial 88 92 Section 17.1417.14 . Force Majeure 88 92 Section 17.1517.15 . Calculations 88 93 Section 17.1617.16 . USA PATRIOT Act 89 93 Section 17.17. Electronic Signatures 93 Exhibit A Form of Note A-1 INDENTURE dated as of May 2September 22, 2017 2020 between Flexion TherapeuticsCARDLYTICS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 96 Section 16.03. Payment of Notes Called for Redemption 83 97 Section 16.04. Restrictions on Redemption 84 97 MISCELLANEOUS PROVISIONS 98 Section 17.01. Provisions Binding on Company’s Successors 84 98 Section 17.02. Official Acts by Successor Corporation 84 98 Section 17.03. Addresses for Notices, Etc. 84 98 Section 17.04. Governing Law; Jurisdiction 85 99 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 100 Section 17.06. Legal Holidays 86 100 Section 17.07. No Security Interest Created 86 101 Section 17.08. Benefits of Indenture 86 101 Section 17.09. Table of Contents, Headings, Etc. 87 101 Section 17.10. Authenticating Agent 87 101 Section 17.11. Execution in Counterparts 88 Counterparts; Electronic Signatures 102 Section 17.12. Severability 88 102 Section 17.13. Waiver of Jury Trial 88 103 Section 17.14. Force Majeure 88 103 Section 17.15. Calculations 88 103 Section 17.16. USA PATRIOT Act 89 103 Section 17.17. Tax Withholding 104 Section 17.18. Service of Process 104 Exhibit A Form of Note A-1 Exhibit B Form of Supplemental Indenture to be Delivered by Subsequent Guarantors B-1 INDENTURE dated as of May 2August 8, 2017 between Flexion Therapeutics, Inc.2025 among PITNEY ▇▇▇▇▇ INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), the Guarantors (as defined in Section 1.01), as guarantors hereunder, and ▇▇▇▇▇ Fargo Bank, National AssociationTRUIST BANK, a national North Carolina banking association organized under the laws of the United States of Americacorporation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.0316.03 . Payment of Notes Called for Redemption 83 89 Section 16.04. 16.04 Restrictions on Redemption 84 89 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 90 Section 17.0217.02 . Official Acts by Successor Corporation 84 90 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 90 Section 17.0417.04 . Governing Law; Jurisdiction 85 91 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.0617.06 . Legal Holidays 86 92 Section 17.0717.07 . No Security Interest Created 86 92 Section 17.0817.08 . Benefits of Indenture 86 92 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 92 Section 17.1017.10 . Authenticating Agent 87 92 Section 17.1117.11 . Execution in Counterparts 88 93 Section 17.1217.12 . Severability 88 Severability; Entire Agreement 93 Section 17.1317.13 . Waiver of Jury Trial 88 93 Section 17.1417.14 . Force Majeure 88 94 Section 17.1517.15 . Calculations 88 94 Section 17.1617.16 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 94 Section 17.17 . Tax Withholding 94 INDENTURE dated as of May 2June 12, 2017 2020 between Flexion TherapeuticsOKTA, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 Statements Required in Certificate or Opinion 91 Section 17.07. Legal Holiday 91 Section 17.08. No Security Interest Created 86 91 Section 17.0817.09. Benefits of Indenture 86 91 Section 17.0917.10. Table of Contents, Headings, Etc. 87 91 Section 17.1017.11. Authenticating Agent 87 91 Section 17.1117.12. Execution in Counterparts 88 92 Section 17.1217.13. Severability 88 93 Section 17.1317.14. Waiver of Jury Trial 88 93 Section 17.1417.15. Force Majeure 88 93 Section 17.1517.16. Calculations 88 93 Section 17.1617.17. USA PATRIOT Act 89 93 Exhibit A Form of Note A-1 INDENTURE dated as of May 220, 2017 2021 between Flexion Therapeutics, Sunnova Energy International Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo BankWilmington Trust, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.03. Payment of Notes Called for Redemption 83 85 Section 16.04. Restrictions on Redemption 84 85 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 85 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 86 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 87 Section 17.06. Legal Holidays 86 87 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 88 Section 17.11. Execution in Counterparts 88 89 Section 17.12. Severability 88 89 Section 17.13. Waiver of Jury Trial 88 89 Section 17.14. Force Majeure 88 89 Section 17.15. Calculations 88 89 Section 17.16. USA U.S.A. PATRIOT Act 89 90 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2April 9, 2017 2018, between Flexion TherapeuticsPURE STORAGE, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.0316.03 . Payment of Notes Called for Redemption 83 89 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 89 Section 17.0117.01 . Provisions Binding on Company’s 's Successors 84 89 Section 17.0217.02 . Official Acts by Successor Corporation 84 89 Section 17.0317.03 . Addresses for Notices, Etc. 84 89 Section 17.0417.04 . Governing Law; Jurisdiction 85 91 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.0617.06 . Legal Holidays 86 92 Section 17.0717.07 . No Security Interest Created 86 92 Section 17.0817.08 . Benefits of Indenture 86 92 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 92 Section 17.1017.10 . Authenticating Agent 87 93 Section 17.1117.11 . Execution in Counterparts 88 94 Section 17.1217.12 . Severability 88 94 Section 17.1317.13 . Waiver of Jury Trial 88 94 Section 17.1417.14 . Force Majeure 88 94 Section 17.1517.15 . Calculations 88 94 Section 17.1617.16 . USA PATRIOT Act 89 95 Section 17.17 . Electronic Signatures 95 Section 17.18 . Tax Withholding 95 Exhibit A Form of Note A-1 INDENTURE dated as of May 2August 27, 2017 2025 between Flexion TherapeuticsNOVAVAX, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo BankTHE BANK OF NEW YORK MELLON TRUST COMPANY, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 85 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 85 Section 17.03. Addresses for Notices, Etc. 84 Etc 85 Section 17.04. Governing Law; Jurisdiction 85 86 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 87 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 88 Section 17.10. Authenticating Agent 87 88 Section 17.11. Execution in Counterparts 88 89 Section 17.12. Severability 88 89 Section 17.13. Waiver of Jury Trial 88 89 Section 17.14. Force Majeure 88 89 Section 17.15. Calculations 88 90 Section 17.16. USA U.S.A. PATRIOT Act 89 Exhibit A Form 90 Section 17.17. No Personal Liability of Note A-1 INDENTURE Directors, Officers, Employees or Stockholders 90 INDENTURE, dated as of May 2June 15, 2017 2020, between Flexion Therapeutics, Inc.COUPA SOFTWARE INCORPORATED, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 84 Section 16.03. Payment of Notes Called for Redemption 83 86 Section 16.04. Restrictions on Redemption 84 86 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 86 Section 17.02. Official Acts by Successor Corporation 84 87 Section 17.03. Addresses for Notices, Etc. 84 87 Section 17.04. Governing Law; Jurisdiction 85 87 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 88 Section 17.06. Legal Holidays 86 89 Section 17.07. No Security Interest Created 86 89 Section 17.08. Benefits of Indenture 86 89 Section 17.09. Table of Contents, Headings, Etc. 87 89 Section 17.10. Authenticating Agent 87 89 Section 17.11. Execution in Counterparts 88 90 Section 17.12. Severability 88 91 Section 17.13. Waiver of Jury Trial 88 91 Section 17.14. Force Majeure 88 91 Section 17.15. Calculations 88 91 Section 17.16. USA U.S.A. PATRIOT Act 89 91 Section 17.17. Withholding Taxes 92 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2March 9, 2017 2021, between Flexion TherapeuticsCUTERA, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 92 Section 16.0316.03 . Payment of Notes Called for Redemption 83 94 Section 16.04. 16.04 Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 95 Section 17.0117.01 . Provisions Binding on Company’s Successors 84 95 Section 17.0217.02 . Official Acts by Successor Corporation 84 95 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 95 Section 17.0417.04 . Governing Law; Jurisdiction 85 96 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 96 Section 17.0617.06 . Legal Holidays 86 97 Section 17.0717.07 . No Security Interest Created 86 97 Section 17.0817.08 . Benefits of Indenture 86 97 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 97 Section 17.1017.10 . Authenticating Agent 87 97 Section 17.1117.11 . Execution in Counterparts 88 98 Section 17.1217.12 . Severability 88 99 Section 17.1317.13 . Waiver of Jury Trial 88 99 Section 17.1417.14 . Force Majeure 88 99 Section 17.1517.15 . Calculations 88 100 Section 17.1617.16 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 100 Section 17.17 . Tax Withholding 100 INDENTURE dated as of May 2August 10, 2017 2021 between Flexion Therapeutics, Inc.UPWORK INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 79 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 80 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 81 Section 17.02. Official Acts by Successor Corporation 84 81 Section 17.03. Addresses for Notices, Etc. 84 Etc 81 Section 17.04. Governing Law; Jurisdiction 85 82 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.06. Legal Holidays 86 83 Section 17.07. No Security Interest Created 86 83 Section 17.08. Benefits of Indenture 86 83 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 83 Section 17.10. Authenticating Agent 87 83 Section 17.11. Execution in Counterparts 88 84 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 85 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 85 INDENTURE dated as of May 2March 6, 2017 between Flexion Therapeutics, Inc.SILICON LABORATORIES INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 Section 16.03. Payment of Notes Called for Redemption 83 84 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 Entity 85 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 Law 86 Section 17.05. Intentionally Omitted 86 Section 17.06. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.0617.07. Legal Holidays 86 Section 17.0717.08. No Security Interest Created 86 87 Section 17.0817.09. Benefits of Indenture 86 87 Section 17.0917.10. Table of Contents, Headings, Etc. 87 Section 17.1017.11. Authenticating Agent 87 Section 17.1117.12. Execution in Counterparts 88 Section 17.1217.13. Severability 88 Section 17.1317.14. Waiver of Jury Trial 88 Section 17.14. Force Majeure Trial; Submission of Jurisdiction 88 Section 17.15. Calculations 88 Force Majeure 89 Section 17.16. USA PATRIOT Calculations 89 Section 17.17. U.S.A. Patriot Act 89 Section 17.18. Tax Withholding 89 Exhibit A Form of Note A-1 INDENTURE dated as of May 2April 4, 2017 between Flexion TherapeuticsCarbonite, Inc., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) ), and ▇▇▇▇▇ Fargo Bank, U.S. Bank National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.03. Payment of Notes Called for Redemption 83 89 Section 16.04. Restrictions on Redemption 84 90 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 90 Section 17.02. Official Acts by Successor Corporation 84 90 Section 17.03. Addresses for Notices, Etc. 84 Etc 90 Section 17.04. Governing Law; Jurisdiction 85 91 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.06. Legal Holidays 86 92 Section 17.07. No Security Interest Created 86 92 Section 17.08. Benefits of Indenture 86 96 Section 17.09. Table of Contents, Headings, Etc. 87 93 Section 17.10. Authenticating Agent 87 93 Section 17.11. Execution in Counterparts 88 95 Section 17.12. Severability 88 94 Section 17.13. Waiver of Jury Trial 88 94 Section 17.14. Force Majeure 88 94 Section 17.15. Calculations 88 94 Section 17.16. USA PATRIOT Act 89 95 Section 17.17. Tax Withholding 95 Exhibit A Form of Note A-1 INDENTURE dated as of May 2March 8, 2017 2024 between Flexion Therapeutics, Inc.MICROSTRATEGY INCORPORATED, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 79 Section 16.03. Payment of Notes Called for Redemption 83 80 Section 16.04. Restrictions on Redemption 84 80 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 81 Section 17.02. Official Acts by Successor Corporation 84 81 Section 17.03. Addresses for Notices, Etc. 84 Etc 81 Section 17.04. Governing Law; Jurisdiction 85 82 Section 17.05. Submission to Jurisdiction; Service of Process 82 Section 17.06. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 82 Section 17.0617.07. Legal Holidays 86 83 Section 17.0717.08. No Security Interest Created 86 83 Section 17.0817.09. Benefits of Indenture 86 83 Section 17.0917.10. Table of Contents, Headings, Etc. 87 Section 17.10. Authenticating Agent 87 Etc 83 Section 17.11. Execution in Counterparts 88 83 Section 17.12. Severability 88 83 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 84 INDENTURE dated as of May 2October 16, 2017 2013 between Flexion Therapeutics, Inc.NQ MOBILE INC., a Delaware corporationCayman Islands company, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationDEUTSCHE BANK TRUST COMPANY AMERICAS, a national New York banking association organized under the laws of the United States of Americacorporation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 88 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 88 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 89 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 90 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 Counterparts; Electronic Signatures 91 Section 17.12. Severability 88 92 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 93 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 216, 2017 2024, between Flexion TherapeuticsMKS INSTRUMENTS, Inc.INC., a Delaware Massachusetts corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.03. Payment of Notes Called for Redemption 83 91 Section 16.04. Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 91 Section 17.02. Official Acts by Successor Corporation 84 Entity 91 Section 17.03. Addresses for Notices, Etc. 84 92 Section 17.04. Governing Law; Jurisdiction 85 92 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 93 Section 17.06. Legal Holidays 86 94 Section 17.07. No Security Interest Created 86 94 Section 17.08. Benefits of Indenture 86 94 Section 17.09. Table of Contents, Headings, Etc. 87 94 Section 17.10. Authenticating Agent 87 94 Section 17.11. Execution in Counterparts 88 95 Section 17.12. Severability 88 95 Section 17.13. Waiver of Jury Trial 88 95 Section 17.14. Force Majeure 88 96 Section 17.15. Calculations 88 96 Section 17.16. USA PATRIOT Act 89 96 Section 17.17. Electronic Signatures 96 Exhibit A Form of Note A-1 INDENTURE dated as of May 2June 13, 2017 2025 between Flexion TherapeuticsRUBRIK, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 91 Section 16.03. Payment of Notes Called for Redemption 83 92 Section 16.04. Restrictions on Redemption 84 93 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 93 Section 17.02. Official Acts by Successor Corporation 84 93 Section 17.03. Addresses for Notices, Etc. 84 93 Section 17.04. Governing Law; Jurisdiction 85 94 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 95 Section 17.06. Legal Holidays 86 95 Section 17.07. No Security Interest Created 86 95 Section 17.08. Benefits of Indenture 86 95 Section 17.09. Table of Contents, Headings, Etc. 87 95 Section 17.10. Authenticating Agent 87 96 Section 17.11. Execution in Counterparts 88 97 Section 17.12. Severability 88 97 Section 17.13. Waiver of Jury Trial 88 97 Section 17.14. Force Majeure 88 97 Section 17.15. Calculations 88 97 Section 17.16. USA PATRIOT Act 89 97 Section 17.17. Electronic Signatures 98 Exhibit A Form of Note A-1 INDENTURE dated as of May 2November 3, 2017 between Flexion Therapeutics, Inc.2023 among WESTERN DIGITAL CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) ), Western Digital Technologies, Inc., as Guarantor, and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 78 Section 16.03. Payment of Notes Called for Redemption 83 79 Section 16.04. Restrictions on Redemption 84 80 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 80 Section 17.02. Official Acts by Successor Corporation 84 80 Section 17.03. Addresses for Notices, Etc. 84 80 Section 17.04. Governing Law; Jurisdiction 85 80 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 81 Section 17.06. Legal Holidays 86 81 Section 17.07. No Security Interest Created 86 82 Section 17.08. Benefits of Indenture 86 82 Section 17.09. Table of Contents, Headings, Etc. 87 82 Section 17.10. Authenticating Agent 87 82 Section 17.11. Execution in Counterparts 88 83 Section 17.12. Severability 88 84 Section 17.13. Waiver of Jury Trial 88 84 Section 17.14. Force Majeure 88 84 Section 17.15. Calculations 88 84 Section 17.16. USA PATRIOT U.S.A. Patriot Act 89 Exhibit A Form of Note A-1 INDENTURE 85 INDENTURE, dated as of May 2February [•], 2017 2021, between Flexion TherapeuticsPACIFIC BIOSCIENCES OF CALIFORNIA, Inc.INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 96 Section 16.03. Payment of Notes Called for Redemption 83 98 Section 16.04. Restrictions on Redemption 84 98 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 99 Section 17.02. Official Acts by Successor Corporation 84 Entity 99 Section 17.03. Addresses for Notices, Etc. 84 Etc 99 Section 17.04. Governing Law; Jurisdiction 85 Law 100 Section 17.05. Intentionally Omitted 100 Section 17.06. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 100 Section 17.0617.07. Legal Holidays 86 101 Section 17.0717.08. No Security Interest Created 86 101 Section 17.0817.09. Benefits of Indenture 86 101 Section 17.0917.10. Table of Contents, Headings, Etc. 87 Etc 101 Section 17.1017.11. Authenticating Agent 87 101 Section 17.1117.12. Execution in Counterparts 88 Counterparts; Electronic Signatures 102 Section 17.1217.13. Severability 88 103 Section 17.1317.14. Waiver of Jury Trial 88 Trial; Submission of Jurisdiction 103 Section 17.1417.15. Force Majeure 88 Section 17.15. Calculations 88 103 Section 17.16. USA PATRIOT Act 89 Calculations 103 Section 17.17. Tax Withholding and Reporting 104 Exhibit A Form of Note A-1 Exhibit B Form of Supplemental Indenture B-1 INDENTURE dated as of May 214, 2017 between Flexion Therapeutics, Inc.2021 among ON Semiconductor Corporation, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) ), the Guarantors listed on the signature page hereof, and ▇▇▇▇▇ Fargo Bank, National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.0316.03 . Payment of Notes Called for Redemption 83 90 Section 16.0416.04 . Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 90 Section 17.0117.01 . Provisions Binding on Company’s Successors 84 90 Section 17.0217.02 . Official Acts by Successor Corporation 84 90 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 90 Section 17.0417.04 . Governing Law; Jurisdiction 85 91 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.0617.06 . Legal Holidays 86 92 Section 17.0717.07 . No Security Interest Created 86 93 Section 17.0817.08 . Benefits of Indenture 86 93 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 93 Section 17.1017.10 . Authenticating Agent 87 93 Section 17.1117.11 . Execution in Counterparts 88 94 Section 17.1217.12 . Severability 88 94 Section 17.1317.13 . Waiver of Jury Trial 88 94 Section 17.1417.14 . Force Majeure 88 94 Section 17.1517.15 . Calculations 88 95 Section 17.1617.16 . USA U.S.A. PATRIOT Act 89 95 Section 17.17 . Tax Withholding 95 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 218, 2017 2020, between Flexion Therapeutics, Inc.PLUG POWER INC., a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 90 Section 16.03. Payment of Notes Called for Redemption 83 91 Section 16.04. Restrictions on Redemption 84 92 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 92 Section 17.02. Official Acts by Successor Corporation 84 92 Section 17.03. Addresses for Notices, Etc. 84 92 Section 17.04. Governing Law; Jurisdiction 85 93 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 94 Section 17.06. Legal Holidays 86 94 Section 17.07. No Security Interest Created 86 94 Section 17.08. Benefits of Indenture 86 95 Section 17.09. Table of Contents, Headings, Etc. 87 95 Section 17.10. Authenticating Agent 87 95 Section 17.11. Execution in Counterparts 88 96 Section 17.12. Severability 88 96 Section 17.13. Waiver of Jury Trial 88 96 Section 17.14. Force Majeure 88 96 Section 17.15. Calculations 88 97 Section 17.16. USA PATRIOT Act 89 97 Section 17.17. Electronic Signatures 97 Section 17.18. Tax Withholding 98 Exhibit A Form of Note A-1 INDENTURE dated as of May 2December 8, 2017 between Flexion Therapeutics2022 among LANTHEUS HOLDINGS, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), LANTHEUS MEDICAL IMAGING, INC., a Delaware corporation and a wholly owned subsidiary of the Company, as guarantor (the “Guarantor,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 89 Section 16.0316.03 . Payment of Notes Called for Redemption 83 90 Section 16.0416.04 . Restrictions on Redemption 84 91 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 91 Section 17.0217.02 . Official Acts by Successor Corporation 84 91 Section 17.0317.03 . Addresses for Notices, Etc. 84 Etc 91 Section 17.0417.04 . Governing Law; Jurisdiction 85 92 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 92 Section 17.0617.06 . Legal Holidays 86 93 Section 17.0717.07 . No Security Interest Created 86 93 Section 17.0817.08 . Benefits of Indenture 86 93 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 Etc 93 Section 17.1017.10 . Authenticating Agent 87 93 Section 17.1117.11 . Execution in Counterparts 88 94 Section 17.1217.12 . Severability 88 95 Section 17.1317.13 . Waiver of Jury Trial 88 95 Section 17.1417.14 . Force Majeure 88 95 Section 17.1517.15 . Calculations 88 95 Section 17.1617.16 . USA PATRIOT Act 89 95 Section 17.17 . Tax Withholding 95 Exhibit A Form of Note A-1 INDENTURE dated as of May 215, 2017 2020 between Flexion TherapeuticsLYFT, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 83 Section 16.03. Payment of Notes Called for Redemption 83 85 Section 16.04. Restrictions on Redemption 84 85 ARTICLE 17 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 85 Section 17.02. Official Acts by Successor Corporation 84 85 Section 17.03. Addresses for Notices, Etc. 84 85 Section 17.04. Governing Law; Jurisdiction 85 86 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 Section 17.06. Legal Holidays 86 87 Section 17.07. No Security Interest Created 86 87 Section 17.08. Benefits of Indenture 86 87 Section 17.09. No Adverse Interpretation of Other Agreements 87 Section 17.10. Table of Contents, Headings, Etc. 87 88 Section 17.1017.11. Authenticating Agent 87 88 Section 17.1117.12. Execution in Counterparts 88 89 Section 17.1217.13. Severability 88 89 Section 17.1317.14. Entire Agreement 89 Section 17.15. Waiver of Jury Trial 88 89 Section 17.1417.16. Force Majeure 88 90 Section 17.1517.17. Calculations 88 90 Section 17.1617.18. USA PATRIOT Act 89 90 Section 17.19. Withholding Taxes 90 Exhibit A Form of Note A-1 INDENTURE dated as of May 227, 2017 2020 between Flexion TherapeuticsUNDER ARMOUR, Inc.INC., a Delaware Maryland corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 88 MISCELLANEOUS PROVISIONS Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 Company 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 Severability; Entire Agreement 93 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA U.S.A. PATRIOT Act 89 94 Section 17.17. Withholding Taxes 94 Exhibit A Form of Note A-1 INDENTURE INDENTURE, dated as of May 2December 14, 2017 2023, between Flexion Therapeutics, Inc.REPLIGEN CORPORATION, a Delaware corporation, as issuer (the “Company,” ”, as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankWILMINGTON TRUST, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” ”, as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 89 Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 89 Section 17.04. Governing Law; Jurisdiction 85 90 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 92 Section 17.10. Authenticating Agent 87 92 Section 17.11. Execution in Counterparts 88 93 Section 17.12. Severability 88 93 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT Act 89 Exhibit A Form of Note A-1 94 Section 17.17. Foreign Account Tax Compliance Act (FATCA) 94 INDENTURE dated as of May 2March 15, 2017 2016 between Flexion TherapeuticsCSG Systems International, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section ‎Section 1.01) and ▇▇▇▇▇ Fargo BankThe Bank of New York Mellon Trust Company, National AssociationN.A., a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section ‎Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 88 Section 16.0316.03 . Payment of Notes Called for Redemption 83 89 Section 16.04. 16.04 Restrictions on Redemption 84 89 MISCELLANEOUS PROVISIONS Section 17.0117.01 . Provisions Binding on Company’s Successors 84 89 Section 17.0217.02 . Official Acts by Successor Corporation 84 90 Section 17.0317.03 . Addresses for Notices, Etc. 84 90 Section 17.0417.04 . Governing Law; Jurisdiction 85 90 Section 17.0517.05 . Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 91 Section 17.0617.06 . Legal Holidays 86 91 Section 17.0717.07 . No Security Interest Created 86 91 Section 17.0817.08 . Benefits of Indenture 86 92 Section 17.0917.09 . Table of Contents, Headings, Etc. 87 92 Section 17.1017.10 . Authenticating Agent 87 92 Section 17.1117.11 . Execution in Counterparts 88 93 Section 17.1217.12 . Severability 88 93 Section 17.1317.13 . Waiver of Jury Trial 88 93 Section 17.1417.14 . Force Majeure 88 93 Section 17.1517.15 . Calculations 88 94 Section 17.1617.16 . USA PATRIOT Act 89 Exhibit A Form of Note A-1 94 Section 17.17 . Tax Withholding 94 INDENTURE dated as of May 215, 2017 2020 between Flexion TherapeuticsCLOUDFLARE, Inc.INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo Bank, National AssociationU.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).

Notice of Optional Redemption. Selection of Notes 82 87 Section 16.03. Payment of Notes Called for Redemption 83 88 Section 16.04. Restrictions on Redemption 84 MISCELLANEOUS PROVISIONS 88 ARTICLE 17 Miscellaneous Provisions Section 17.01. Provisions Binding on Company’s Successors 84 89 Section 17.02. Official Acts by Successor Corporation 84 89 Section 17.03. Addresses for Notices, Etc. 84 Etc 89 Section 17.04. Governing Law; Jurisdiction 85 89 Section 17.05. Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee 86 90 Section 17.06. Legal Holidays 86 91 Section 17.07. No Security Interest Created 86 91 Section 17.08. Benefits of Indenture 86 91 Section 17.09. Table of Contents, Headings, Etc. 87 Etc 91 Section 17.10. Authenticating Agent 87 91 Section 17.11. Execution in Counterparts 88 92 Section 17.12. Severability 88 93 Section 17.13. Waiver of Jury Trial 88 93 Section 17.14. Force Majeure 88 93 Section 17.15. Calculations 88 93 Section 17.16. USA PATRIOT Act 89 93 Section 17.17. Withholding Taxes 94 Exhibit A Form of Note A-1 INDENTURE dated as of May 2February 26, 2017 2024 between Flexion Therapeutics, Inc.▇▇▇▇▇▇▇ CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and ▇▇▇▇▇ Fargo BankU.S. BANK TRUST COMPANY, National AssociationNATIONAL ASSOCIATION, a national banking association organized under the laws of the United States of Americaassociation, as trustee (the “Trustee,” as more fully set forth in Section 1.01).